HORIZONH2020FP7
Fondation Cardiometabolisme Nutrition
- Country
- FRFrance
- Defence projects
- 0
- Projects, all programmes
- 13
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 4,494,397
- Active
- 2012 to 2024
Projects
13 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| LIVERAIMA Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy | HORIZON | 2024 | Participant | EUR 540,313 |
| ARTEMISAcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients | HORIZON | 2024 | Participant | EUR 475,000 |
| EDC-MASLDInvestigation of endocrine-disrupting chemicals as contributors to progression of metabolic dysfunction-associated steatotic liver disease | HORIZON | 2024 | Participant | EUR 310,000 |
| DCM-NEXTEnabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families. | HORIZON | 2023 | Participant | EUR 324,783 |
| GRIPonMASHGRIP on MASH: Global Research Initiative for Patient Screening on MASH | HORIZON | 2023 | Participant | EUR 640,000 |
| HORUSCasting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation | HORIZON | 2022 | Third party | Not stated |
| MAESTRIAMachine Learning Artificial Intelligence Early Detection Stroke Atrial Fibrillation | H2020 | 2021 | Third party | Not stated |
| EU-PEARLEU Patient- cEntric clinicAl tRial pLatform | H2020 | 2019 | Third party | Not stated |
| LITMUSLiver Investigation: Testing Marker Utility in Steatohepatitis | H2020 | 2017 | Participant | EUR 621,750 |
| EPoSElucidating Pathways of Steatohepatitis | H2020 | 2015 | Participant | EUR 1,012,318 |
| COMBACTE-MAGNETCombatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections | FP7 | 2015 | Participant | EUR 301,900 |
| MON4STRATTherapeutic Beta-Lactam Monitoring for Stratified Treatment of hospital-acquired pneumonia, improved dose-dependent efficacy, decreased treatment duration, and prevention of emergence of resistance | FP7 | 2014 | Participant | EUR 268,334 |
| METACARDISMetagenomics in Cardiometabolic Diseases | FP7 | 2012 | Participant | Not stated |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.